Updated Understanding of the Molecular Targets of Radioiodine in Differentiated Thyroid Cancer
Acta Endocrinologica (Bucharest) · 2022 · 18 (1) · 86-92
DOI: 10.4183/aeb.2022.86 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Endocrinologica (Bucharest), 2022. Verfasst von Y Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Cancer Hospital - Department of Head and Neck Surgery, Wuhan, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hubei Cancer Hospital - Department of Head and Neck Surgery, Wuhan, China.
- First People's Hospital of Yichang - Department of General Surgery II, Yichang, Hubei, China.
- Liuzhou Traditional Chinese Medical Hospital - Department of Otolaryngology & Head and Neck Surgery, Liuzhou, Guangxi, China.
Zitieren
APA
Zhang, Y., Zou, W., Zhu, X., Jiang, L., Gui, C., Fan, Q., Tu, Y., & Chen, J. (2022). Updated Understanding of the Molecular Targets of Radioiodine in Differentiated Thyroid Cancer. Acta Endocrinologica (Bucharest), 18(1), 86-92. https://doi.org/10.4183/aeb.2022.86
Vancouver
Zhang Y, Zou W, Zhu X, Jiang L, Gui C, Fan Q, et al. Updated Understanding of the Molecular Targets of Radioiodine in Differentiated Thyroid Cancer. Acta Endocrinologica (Bucharest). 2022;18(1):86-92. doi:10.4183/aeb.2022.86
BibTeX
@article{Zhang2022,
author = {Zhang, Y and Zou, W and Zhu, X and Jiang, L and Gui, C and Fan, Q and Tu, Y and Chen, J},
title = {Updated Understanding of the Molecular Targets of Radioiodine in Differentiated Thyroid Cancer},
journal = {Acta Endocrinologica (Bucharest)},
year = {2022},
volume = {18},
number = {1},
pages = {86--92},
doi = {10.4183/aeb.2022.86}
}
EUVIMED